CVS CEO reports RSU grant and tax share surrender
CVS Health President, CEO and Chair J. David Joyner reported routine equity compensation activity.
Rhea-AI Filing Summary
CVS Health President, CEO and Chair J. David Joyner reported routine equity compensation activity. He received 86,326 shares of Common Stock in the form of restricted stock units under the company’s 2017 Incentive Compensation Plan, valued at $71.82 per share. These RSUs vest in three equal installments beginning on March 31, 2027.
In a separate transaction tied to RSU vesting and settlement, Joyner surrendered 8,029 shares of common stock at $72.49 per share to cover withholding tax obligations. After this tax-withholding disposition, he directly holds 70,349 shares of CVS common stock and 160,860 RSUs. These are non‑open‑market, compensation-related transactions rather than discretionary stock purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Joyner J. David
Role
President, CEO and Chair
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 8,029 | $72.49 | $582K |
| Grant/Award | Common Stock (RSUs) | 86,326 | $71.82 | $6.20M |
Holdings After Transaction:
Common Stock (RSUs) — 160,860 shares (Direct);
Common Stock — 70,349 shares (Direct)
Footnotes (2)
- F1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.
- F2. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
Key Figures
RSU grant: 86,326 RSUs
RSU grant price: $71.82 per share
Tax-withheld shares: 8,029 shares
+4 more
7 metrics
RSU grant
86,326 RSUs
Restricted stock units awarded; price $71.82 per share
RSU grant price
$71.82 per share
Value per share for 86,326 RSUs granted
Tax-withheld shares
8,029 shares
Shares surrendered to cover withholding taxes
Tax-withholding price
$72.49 per share
Value per share for 8,029 surrendered shares
Common shares after disposition
70,349 shares
Direct CVS common stock holdings after tax-withholding disposition
RSUs after grant
160,860 RSUs
Total restricted stock units held after new award
RSU vesting start date
March 31, 2027
Restrictions lapse in three equal installments from this date
Key Terms
restricted stock units, 2017 Incentive Compensation Plan, withholding taxes, tax-withholding disposition
4 terms
restricted stock units financial
"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2017 Incentive Compensation Plan financial
"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
withholding taxes financial
"Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units."
Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CVS (CVS) CEO J. David Joyner report in this Form 4 filing?
J. David Joyner reported a grant of 86,326 restricted stock units and a related tax-withholding share surrender. These are compensation and tax events, not open-market trades, reflecting routine equity-based pay rather than a change in his investment stance.
How many CVS (CVS) restricted stock units were granted to the CEO and when do they vest?
Joyner received 86,326 restricted stock units under CVS’s 2017 Incentive Compensation Plan. The restrictions lapse in three equal installments, starting on March 31, 2027. This schedule gradually delivers full ownership over time, aligning his compensation with long-term company performance.
What are J. David Joyner’s CVS (CVS) holdings after these Form 4 transactions?
After the tax-withholding disposition, Joyner directly holds 70,349 shares of CVS common stock. Following the RSU grant, he also holds 160,860 restricted stock units, which represent additional potential future shares as the restrictions lapse over time.
Are the CVS (CVS) CEO’s reported transactions likely to be viewed as routine compensation events?
Yes. The Form 4 shows a large RSU grant under the 2017 Incentive Compensation Plan and a tax-withholding share surrender. Both are standard components of executive equity compensation programs rather than market-driven buying or selling decisions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
